CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins

Virology

Volumn 327, Issue 1, 2004, Pages 144-154

  Chung, Chungwon ^a   Mealey, Robert H ^a   McGuire, Travis C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Capsid; Cytotoxic T lymphocyte; Epitope cluster; Equine infectious anemia virus; Gag; Horse MHC class I allele; Matrix

Indexed keywords

GAG PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLELE; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DNA POLYMORPHISM; EQUINE INFECTIOUS ANEMIA VIRUS; GENETIC VARIABILITY; HORSE; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS CARRIER;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; CAPSID PROTEINS; CARRIER STATE; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; EQUINE INFECTIOUS ANEMIA; GENE PRODUCTS, GAG; HISTOCOMPATIBILITY ANTIGENS CLASS I; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC; VIRAL MATRIX PROTEINS;

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; EQUUS CABALLUS;

EID: 4344663860     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.06.035     Document Type: Article

References (51)

1. L.C. Anton, J.W. Yewdell, and J.R. Bennink MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies J. Immunol. 158 1997 2535 2542
2. E. Bailey Identification and genetics of horse lymphocyte alloantigens Immunogenetics 11 1980 499 506
3. E. Bailey, E. Marti, D.G. Fraser, D.F. Antczak, and S. Lazary Immunogenetics of the horse A.T. Bowling A. Ruvinsky The Genetics of the Horse 2000 CABI Publishing Inc. UK 123 155
4. D. Bernoco, G. Byrns, E. Bailey, and A.M. Lew Evidence of a second polymorphic ELA class I (ELA-B) locus and gene order for three loci of the equine major histocompatibility complex Anim. Genet. 18 1987 103 118
5. F. Buseyne, M. McChesney, F. Porrot, S. Kovarik, B. Guy, and Y. Riviere Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: gag epitopes are clustered in three regions of the p24gag protein J. Virol. 67 1993 694 702
6. S. Carpenter, L.H. Evans, M. Sevoian, and B. Chesebro Role of the host immune response in selection of equine infectious anemia virus variants J. Virol. 61 1987 3783 3789
7. C. Chung, S.R. Leib, D.G. Fraser, S.A. Ellis, and T.C. McGuire Novel classical MHC class I alleles identified in horses by sequencing clones of reverse transcription-PCR products Eur. J. Immunogenet. 30 2003 387 396
8. L. Coggins Carriers of equine infectious anemia virus J. Am. Vet. Med. Assoc. 184 1984 279 281
9. S. Dupont, N. Sharova, C. DeHoratius, C.M. Virbasius, X. Zhu, A.G. Bukrinskaya, M. Stevenson, and M.R. Green A novel nuclear export activity in HIV-1 matrix protein required for viral replication Nature 402 1999 681 685
10. S.A. Ellis, A.J. Martin, E.C. Holmes, and W.I. Morrison At least four MHC class I genes are transcribed in the horse: phylogenetic analysis suggests an unusual evolutionary history for the MHC in this species Eur. J. Immunogenet. 22 1995 249 260
11. D.T. Evans, L.A. Knapp, P. Jing, J.L. Mitchen, M. Dykhuizen, D.C. Montefiori, C.D. Pauza, and D.I. Watkins Rapid and slow progressors differ by a single MHC class I haplotype in a family of MHC-defined rhesus macaques infected with SIV Immunol. Lett. 66 1999 53 59
12. P. Goulder, D. Price, M. Nowak, S. Rowland-Jones, R. Phillips, and A. McMichael Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses Immunol. Rev. 159 1997 17 29
13. P.J. Goulder, C. Brander, K. Annamalai, N. Mngqundaniso, U. Govender, Y. Tang, S. He, K.E. Hartman, C.A. O'Callaghan, G.S. Ogg, M.A. Altfeld, E.S. Rosenberg, H. Cao, S.A. Kalams, M. Hammond, M. Bunce, S.I. Pelton, S.A. Burchett, K. McIntosh, H.M. Coovadia, and B.D. Walker Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and Caucasoid adults and children J. Virol. 74 2000 5679 5690
14. P.J. Goulder, Y. Tang, S.I. Pelton, and B.D. Walker HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other J. Virol. 74 2000 5291 5299
15. P.J. Goulder, C. Pasquier, E.C. Holmes, B. Liang, Y. Tang, J. Izopet, K. Saune, E.S. Rosenberg, S.K. Burchett, K. McIntosh, M. Barnardo, M. Bunce, B.D. Walker, C. Brander, and R.E. Phillips Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation Immunol. Lett. 79 2001 109 116
16. S.A. Hammond, S.J. Cook, D.L. Lichtenstein, C.J. Issel, and R.C. Montelaro Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process J. Virol. 71 1997 3840 3852
17. S.A. Hammond, F. Li, B.M. McKeon, S.J. Cook, C.J. Issel, and R.C. Montelaro Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus J. Virol. 74 2000 5968 5981
18. H. Hatanaka, O. Iourin, Z. Rao, E. Fry, A. Kingsman, and D.I. Stuart Structure of equine infectious anemia virus matrix protein J. Virol. 76 2002 1876 1883
19. C.J. Issel, D.W. Horohov, D.F. Lea, W.V. Adams, S.D. Hagius, J.M. McManus, A.C. Allison, and R.C. Montelaro Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus J. Virol. 66 1992 3398 3408
20. A. Kaur, L. Alexander, S.I. Staprans, L. Denekamp, C.L. Hale, H.M. McClure, M.B. Feinberg, R.C. Desrosiers, and R.P. Johnson Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection Eur. J. Immunol. 31 2001 3207 3217
21. A.D. Kelleher, C. Long, E.C. Holmes, R.L. Allen, J. Wilson, C. Conlon, C. Workman, S. Shaunak, K. Olson, P. Goulder, C. Brander, G. Ogg, J.S. Sullivan, W. Dyer, I. Jones, A.J. McMichael, S. Rowland-Jones, and R.E. Phillips Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses J. Exp. Med. 193 2001 375 386
22. Y. Kono Viremia and immunological responses in horses infected with equine infectious anemia virus Natl. Inst. Anim. Health Q. (Tokyo) 9 1969 1 9
23. Y. Kono, K. Kobayashi, and Y. Fukunaga Immunization of horses against equine infectious anemia (EIA) with an attenuated EIA virus Natl. Inst. Anim. Health Q. (Tokyo) 10 1970 113 122
24. Y. Kono, K. Kobayashi, and Y. Fukunaga Antigenic drift of equine infectious anemia virus in chronically infected horses Arch. Gesamte Virusforsch. 41 1973 1 10
25. M.J. Kuroda, J.E. Schmitz, W.A. Charini, C.E. Nickerson, M.A. Lifton, C.I. Lord, M.A. Forman, and N.L. Letvin Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys J. Immunol. 162 1999 5127 5133
26. S. Lazary, D.F. Antczak, E. Bailey, T.K. Bell, D. Bernoco, G. Byrns, and J.J. McClure Joint report of the Fifth International Workshop on Lymphocyte Alloantigens of the Horse, Baton Rouge, Louisiana, 31 Octoberâ€" 1 November 1987 Anim. Genet. 19 1988 447 456
27. T.C. McGuire, D.B. Tumas, K.M. Byrne, M.T. Hines, S.R. Leib, A.L. Brassfield, K.I. O'Rourke, and L.E. Perryman Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins J. Virol. 68 1994 1459 1467
28. T.C. McGuire, S.R. Leib, S.M. Lonning, W. Zhang, K.M. Byrne, and R.H. Mealey Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses J. Gen. Virol. 81 2000 2735 2739
29. R.H. Mealey, D.G. Fraser, J.L. Oaks, G.H. Cantor, and T.C. McGuire Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses Clin. Immunol. 101 2001 237 247
30. R.H. Mealey, B. Zhang, S.R. Leib, M.H. Littke, and T.C. McGuire Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus Virology 313 2003 537 552
31. R.C. Montelaro, B. Parekh, A. Orrego, and C.J. Issel Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus J. Biol. Chem. 259 1984 10539 10544
32. R.C. Montelaro, J.M. Ball, and K.E. Rushlow Equine retroviruses J.A. Levy The Retroviridae 1993 Plenum Press New York, N.Y 257 360
33. V. Novitsky, H. Cao, N. Rybak, P. Gilbert, M.F. McLane, S. Gaolekwe, T. Peter, I. Thior, T. Ndung'u, R. Marlink, T.H. Lee, and M. Essex Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C J. Virol. 76 2002 10155 10168
34. G.S. Ogg, X. Jin, S. Bonhoeffer, P.R. Dunbar, M.A. Nowak, S. Monard, J.P. Segal, Y. Cao, S.L. Rowland-Jones, V. Cerundolo, A. Hurley, M. Markowitz, D.D. Ho, D.F. Nixon, and A.J. McMichael Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA Science 279 1998 2103 2106
35. K. O'Rourke, L.E. Perryman, and T.C. McGuire Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus J. Gen. Virol. 69 1988 667 674
36. L.E. Perryman, K.I. O'Rourke, and T.C. McGuire Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection J. Virol. 62 1988 3073 3076
37. M.L. Raabe, C.J. Issel, S.J. Cook, R.F. Cook, B. Woodson, and R.C. Montelaro Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement Virology 245 1998 151 162
38. P.M. Rwambo, C.J. Issel, W.V. Adams Jr., K.A. Hussain, M. Miller, and R.C. Montelaro Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection Arch. Virol. 111 1990 199 212
39. P.M. Rwambo, C.J. Issel, K.A. Hussain, and R.C. Montelaro In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV) Arch. Virol. 111 1990 275 280
40. J.E. Schmitz, M.J. Kuroda, S. Santra, V.G. Sasseville, M.A. Simon, M.A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B.J. Scallon, J. Ghrayeb, M.A. Forman, D.C. Montefiori, E.P. Rieber, N.L. Letvin, and K.A. Reimann Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes Science 283 1999 857 860
41. D.C. Sellon, F.J. Fuller, and T.C. McGuire The immunopathogenesis of equine infectious anemia virus Virus Res. 32 1994 111 138
42. R.F. Siliciano, A.D. Keegan, R.Z. Dintzis, H.M. Dintzis, and H.S. Shin The interaction of nominal antigen with T cell antigen receptors I. Specific binding of multivalent nominal antigen to cytolytic T cell clones J. Immunol. 135 1985 906 914
43. R. Wagner, B. Leschonsky, E. Harrer, C. Paulus, C. Weber, B.D. Walker, S. Buchbinder, H. Wolf, J.R. Kalden, and T. Harrer Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication J. Immunol. 162 1999 3727 3734
44. B.D. Walker, and B.T. Korber Immune control of HIV: the obstacles of HLA and viral diversity Nat. Immunol. 2 2001 473 475
45. S.Z. Wang, K.E. Rushlow, C.J. Issel, R.F. Cook, S.J. Cook, M.L. Raabe, Y.H. Chong, L. Costa, and R.C. Montelaro Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein Virology 199 1994 247 251
46. C.C. Wilson, S.A. Kalams, B.M. Wilkes, D.J. Ruhl, F. Gao, B.H. Hahn, I.C. Hanson, K. Luzuriaga, S. Wolinsky, R. Koup, S.P. Buchbinder, R.P. Johnson, and B.D. Walker Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition J. Virol. 71 1997 1256 1264
47. T. Woodberry, J. Gardner, L. Mateo, D. Eisen, J. Medveczky, I.A. Ramshaw, S.A. Thomson, R.A. Ffrench, S.L. Elliott, H. Firat, F.A. Lemonnier, and A. Suhrbier Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes J. Virol. 73 1999 5320 5325
48. C.R. Wyatt, W.C. Davis, T.C. McGuire, and L.E. Perryman T lymphocyte development in horses: I. Characterization of monoclonal antibodies identifying three stages of T lymphocyte differentiation Vet. Immunol. Immunopathol. 18 1988 3 18
49. K. Yusim, C. Kesmir, B. Gaschen, M.M. Addo, M. Altfeld, S. Brunak, A. Chigaev, V. Detours, and B.T. Korber Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation J. Virol. 76 2002 8757 8768
50. W. Zhang, S.M. Lonning, and T.C. McGuire Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection J. Virol. 72 1998 9612 9620
51. W. Zhang, D.B. Auyong, J.L. Oaks, and T.C. McGuire Natural variation of equine infectious anemia virus Gag protein cytotoxic T lymphocyte epitopes Virology 261 1999 242 252